title: Deep brain stimulation of the nucleus accumbens shell attenuates cocaine reinstatement through local and antidromic activation.
abstract: Accumbal deep brain stimulation (DBS) is a promising therapeutic modality for the treatment of addiction. Here, we demonstrate that DBS in the nucleus accumbens shell, but not the core, attenuates cocaine priming-induced reinstatement of drug seeking, an animal model of relapse, in male Sprague Dawley rats. Next, we compared DBS of the shell with pharmacological inactivation. Results indicated that inactivation using reagents that influenced (lidocaine) or spared (GABA receptor agonists) fibers of passage blocked cocaine reinstatement when administered into the core but not the shell. It seems unlikely, therefore, that intrashell DBS influences cocaine reinstatement by inactivating this nucleus or the fibers coursing through it. To examine potential circuit-wide changes, c-Fos immunohistochemistry was used to examine neuronal activation following DBS of the nucleus accumbens shell. Intrashell DBS increased c-Fos induction at the site of stimulation as well as in the infralimbic cortex, but had no effect on the dorsal striatum, prelimbic cortex, or ventral pallidum. Recent evidence indicates that accumbens DBS antidromically stimulates axon terminals, which ultimately activates GABAergic interneurons in cortical areas that send afferents to the shell. To test this hypothesis, GABA receptor agonists (baclofen/muscimol) were microinjected into the anterior cingulate, and prelimbic or infralimbic cortices before cocaine reinstatement. Pharmacological inactivation of all three medial prefrontal cortical subregions attenuated the reinstatement of cocaine seeking. These results are consistent with DBS of the accumbens shell attenuating cocaine reinstatement via local activation and/or activation of GABAergic interneurons in the medial prefrontal cortex via antidromic stimulation of cortico-accumbal afferents.
authors.affiliation: Center for Neurobiology and Behavior, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. fair.vassoler@gmail.com
authors.forename: Fair M
authors.initials: FM
authors.lastname: Vassoler
authors.forename: Samantha L
authors.initials: SL
authors.lastname: White
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Hopkins
authors.forename: Leonardo A
authors.initials: LA
authors.lastname: Guercio
authors.forename: Julie
authors.initials: J
authors.lastname: Espallergues
authors.forename: Olivier
authors.initials: O
authors.lastname: Berton
authors.forename: Heath D
authors.initials: HD
authors.lastname: Schmidt
authors.forename: R Christopher
authors.initials: RC
authors.lastname: Pierce
mesh_terms: D000818:Animals; D003042:Cocaine / Q000494:pharmacology*; D046690:Deep Brain Stimulation; D058999:Drug-Seeking Behavior / Q000187:drug effects / Q000502:physiology*; D018755:GABA Agonists / Q000494:pharmacology; D059330:GABAergic Neurons / Q000502:physiology; D007395:Interneurons / Q000502:physiology; D008297:Male; D009714:Nucleus Accumbens / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D018755:GABA Agonists; D003042:Cocaine